- NCIt
- C2918
Loading cancer entity…
Loading cancer entity…
Clinical trials
7 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02005770 | Anesthesia and Circulating Tumor Cells in Breast Cancer | completed | Phase 4 | 221 | University of ZurichOTHER | 1 | Apr 14, 2020 | clinicaltrials |
| NCT04290585 | Technology and Health Communication in Improving Health Outcomes in Patients Scheduled for Mammography | completed | N/A | 160 | Fox Chase Cancer CenterOTHER | 1 | Mar 2, 2020 | clinicaltrials |
| NCT01643148 |
| The Tetrad BMI, Leptin, Leptin/Adiponectin (L/A) Ratio and CA-15-3 is a Reliable Biomarker of Breast Cancer(leptin) |
| completed |
| — |
| 88 |
| Materno-Perinatal Hospital of the State of MexicoOTHER |
| 0 |
| Jul 18, 2012 |
| clinicaltrials |
Data updated 23 days agoSource updated Apr 14, 2020source: clinicaltrials